Aryavan Enterprise Ltd Q2 Results
- BSE: 539455
- NSE: -
- ISIN: INE360S01012
- Sector: Biotechnology & Drugs
BSE
52.25
1.53 (3.02%)
1.53 (3.02%)Volume18.12 K
Updated: Fri 6 Feb, 2026 | 15:24:54
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹10.84 Cr.(69.52%)
- Operating Profit₹0.41 Cr.(42.30%)
- Profit After Tax₹0.52 Cr.(108.83%)
- Operating Margin3.76%(-16.06%)
Note: Comparison is on YoY basis
Quarterly - Aryavan Enterprise Ltd Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 25 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 10.43 | 13.76 | -24.17% | 6.11 | 70.80% |
| Depreciation/ Amortization | 0.04 | 0.04 | 2.10% | - | N/A |
| Operating Income | 0.41 | 0.80 | -49.32% | 0.29 | 42.30% |
| Net Income | 0.52 | 0.61 | -13.62% | 0.25 | 108.83% |
| Other Operating Expenses Total | 0.12 | 0.12 | 3.17% | 0.02 | 673.08% |
| Net Income Before Taxes | 0.67 | 0.90 | -25.07% | 0.33 | 104.84% |
| Total Revenue | 10.84 | 14.57 | -25.56% | 6.40 | 69.52% |
| Selling/ General/ Admin Expenses Total | 0.31 | 0.23 | 37.80% | 0.03 | 997.53% |
| Diluted Normalized EPS | 0.83 | 0.87 | -4.60% | 0.65 | 27.69% |